Paul F. Lizzul
Net Worth

Last updated:

What is Paul F. Lizzul net worth?

The estimated net worth of Dr. Paul F. Lizzul is at least $1,357,884 as of 23 Sep 2024. He owns shares worth $304,726 as insider, has earned $373,638 from insider trading and has received compensation worth at least $679,520 in AnaptysBio, Inc..

What is the salary of Paul F. Lizzul?

Dr. Paul F. Lizzul salary is $339,760 per year as Chief Medical Officer in AnaptysBio, Inc..

How old is Paul F. Lizzul?

Dr. Paul F. Lizzul is 50 years old, born in 1975.

What stocks does Paul F. Lizzul currently own?

As insider, Dr. Paul F. Lizzul owns shares in one company:

Company Title Shares Price per share Total value
AnaptysBio, Inc. (ANAB) Chief Medical Officer 15,398 $19.79 $304,726

What does AnaptysBio, Inc. do?

AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of various dermatological inflammatory diseases; Rosnilimab, an anti-PD-1 agonist antibody program designed to augment PD-1 signaling through rosnilimab treatment to suppress T-cell driven human inflammatory diseases; and ANB032, an anti-BTLA modulator antibody applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation. The company also focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has a collaboration and license agreement with GlaxoSmithKline, Inc. and Bristol-Myers Squibb; and license agreements with United Kingdom Research and Innovation, as well as Millipore Corporation. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.

ANAB logo
ANAB
AnaptysBio, Inc.
$19.79

Paul F. Lizzul insider trading

AnaptysBio, Inc.

Dr. Paul F. Lizzul has made 6 insider trades between 2023-2024, according to the Form 4 filled with the SEC. Most recently he sold 1,500 units of ANAB stock worth $58,005 on 23 Sep 2024.

The largest trade he's ever made was exercising 6,145 units of ANAB stock on 6 Jan 2024. As of 23 Sep 2024 he still owns at least 15,398 units of ANAB stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 1,500 $38.67 $58,005
Option
Common Stock 1,500 $18.5 $27,750
Option
Common 1,500 $18.5 $27,750
Sale
Common Stock 2,220 $38.93 $86,425
Option
Restricted Stock Unit 6,000 N/A N/A
Option
Common Stock 6,000 N/A N/A
Option
Common 2,000 $18.5 $37,000
Option
Common Stock 2,000 $18.5 $37,000
Sale
Common Stock 2,000 $40 $80,000
Option
Common Stock 1,500 $18.5 $27,750
Sale
Common Stock 1,500 $35 $52,500
Option
Common 1,500 $18.5 $27,750
Sale
Common Stock 2,554 $21.81 $55,703
Option
Common Stock 6,145 N/A N/A
Option
Restricted Stock Unit 6,145 N/A N/A
Sale
Common Stock 2,105 $19.48 $41,005
Option
Restricted Stock Unit 6,000 N/A N/A
Option
Common Stock 6,000 N/A N/A

AnaptysBio key executives

AnaptysBio, Inc. executives and other stock owners filed with the SEC: